Related Experiment Video
Updated: May 11, 2025

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
Published on: September 23, 2014
Research progress on ADAM28 in malignant tumors
Lanlan Zhao1, Wei Liu1, Fei Wang2
1Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Weiqi Road, Jinan, 250021, Shandong, China.
A disintegrin and metalloproteinase (ADAM) 28 is a key protein in malignant tumors, driving proliferation and metastasis. Inhibiting ADAM28 shows promise for cancer therapy and diagnosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- ADAM28 is a metalloproteinase involved in cell adhesion, fusion, and protein shedding.
- It plays a role in various biological processes and signaling pathways.
Purpose of the Study:
- To examine the structure and function of ADAM28.
- To investigate its role in human malignant tumor development and progression.
- To explore its potential as a prognostic indicator and therapeutic target.
Main Methods:
- Literature review and analysis of existing research on ADAM28.
- Examination of ADAM28's substrates and mechanisms of action in cancer.
- Investigation of ADAM28's correlation with tumor characteristics.
Main Results:
- ADAM28 is highly expressed in malignant tumors.
- It promotes tumor proliferation, metastasis, and drug resistance.
- ADAM28 influences cell adhesion via substrates like IGFBP-3, vWF, and CTGF.
Conclusions:
- ADAM28 is a crucial factor in malignant tumor progression.
- Inhibiting ADAM28 may impede tumor growth and metastasis.
- ADAM28 holds potential as a prognostic biomarker and therapeutic target for cancer.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...